Print Page | Sign In | Join ISSX
Past Webinar Recordings
Share |
The ISSX Webinar Series recordings are linked below. Additional recordings will be added as they become available.

Please note: The webinar recordings are an exclusive benefit of membership with ISSX and are available only for individual use. You may not share or forward these links to anyone without the express permission of ISSX.


David Rodrigues, PhD, Pfizer 

September 15, 2020: Induction of Drug Transporters in vitro and in vivo: From Gut ABCs to Liver SLCs and Back Again

Malcolm Rowland, PhD, University of Manchester

September 1, 2020: Clearing Up Clearance in PK: What You Need to Know


Tom Baillie, PhD, University of Washington; Kathy Giacomini, PhD, UCSF; Valerie Kramlinger, PhD, Novartis; and David Stresser, PhD, AbbVie

August 14, 2020From Studentship to Early Career Professional: Navigating the Transition from Academia to Industry

Cyrus Khojasteh, PhD, Genentech

July 17, 2020: Biotransformation in the Context of Drug Design: Steps Taken to Enhance Drug Properties

Xinning Yang, Ph.D., Policy Lead at at FDA

June 30, 2020: Update on FDA's Final Drug-Drug Interaction Guidance



Lance Heinle, Senior Scientist II at AbbVie and John Janiszewski, Research Scientist at National Center for Advancing Translational Sciences at NIH

June 18, 2020: High throughput ADME Bioanalysis - It's a Sprint, Not a Marathon

Janne Backman, M.D., Ph.D., Professor at University of Helsinki in Clinical Pharmacology and Individual Medicine

May 5, 2020: Clinical Approaches to Decipher Complex Drug-Drug Interactions

Leslie Benet, Ph.D., Professor at UCSF Department of Bioengineering and Therapeutic Sciences

February 20, 2020: Relatively New Thoughts on the Oldest Clinical Pharmacology Parameter: Half-Life

2019: The Use of BDDCS to Predict Drug Disposition in Drug Development of NMEs

Jashvant Unadkat, Ph.D., Milo Gibaldi Endowed Professor at the School of Pharmacy, University of Washington, Seattle

2019: The Next Frontier in ADME Research: Predicting Tissue Drug Concentrations

Yuichi Sugiyama, Ph.D., Sugiyama Laboratory, RIKEN Innovation Center

2019: Substrate-dependent Inhibition & Time-dependent Inhibition of OATP1B & its Impact on DDI Prediction

2018: The Use of “Extended Clearance Concept” and PBPK Modeling to Interpret Clinical Outcomes from In Vitro Metabolism and Transport Data; Focusing on the Transporters in the Liver

Bhagwat Prasad, Ph.D., Associate Professor, Department of Pharmaceutical Sciences - Washington State University

2019: Importance of Quantitative Training to Address Rigor and Reproducibility in DMPK/PD Research

Phil Smith, Ph.D., Associate Professor, Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy - University of North Carolina at Chapel Hill

2018: Quantitative Targeted Absolute Proteomics (QTAP): Methods and Applications for Studies of Proteins that Modulate Xenobiotic Disposition

Tommy B. Andersson, Ph.D., AstraZeneca, Cardiovascular and Metabolic Diseases

2018: CYP3A Biomarkers in Humans for Drug Interaction Studies

Dennis A. Smith, Ph.D.

2019: Drug Failures, Lessons for Future Drugs

2018: Physicochemistry and ADMET

R. Scott Obach, Ph.D. and Greg S. Walker Ph.D., Pfizer, Inc.

2018: Biosynthesis of Drug Metabolites for Use in DMPK Experiments and Late-Stage Lead Diversification